NCT03732638 Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults Status COMPLETED Phase PHASE2/PHASE3
NCT03729284 A Study of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Status WITHDRAWN Phase PHASE4
NCT03728478 STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS Status RECRUITING Phase PHASE3
NCT03727750 Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML Status COMPLETED Phase PHASE4
NCT03727477 Efficacy of Treatment Sequences in Patients With Non-small Cell Lung Cancer Receiving Lorlatinib Status COMPLETED Phase N/A
NCT03726333 Hepatic Impairment Study for Lorlatinib in Cancer Patients Status TERMINATED Phase PHASE1
NCT03723954 Heart Rate Variations of Golf Fans During the 2018 the Ryder Cup Status COMPLETED Phase N/A
NCT03722966 Effectiveness of Combination Varenicline and Oral Nicotine Replacement Therapy (COMBO) Status TERMINATED Phase PHASE2
NCT03722706 Improving Therapeutic Patient Education for Atopic Dermatitis: Evaluation of a Parent Handbook Status COMPLETED Phase NA
NCT03722238 Actual Use and Compliance Study Of Ibuprofen 600 Mg Immediate Release/Extended Release Tablets In At-Risk OTC Consumers Status TERMINATED Phase PHASE3
NCT03720470 Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy Status COMPLETED Phase PHASE3
NCT03719768 Avelumab With Radiotherapy in Patients With Leptomeningeal Disease Status COMPLETED Phase PHASE1
NCT03715829 A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects Status COMPLETED Phase PHASE2
NCT03709680 Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03709082 Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT03704298 Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma Status TERMINATED Phase PHASE1